KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Community Health Systems (CYH) Shares Outstanding (Diluted Average) (2018 - 2025)

Community Health Systems (CYH) has disclosed Shares Outstanding (Diluted Average) for 11 consecutive years, with $135.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 2.12% year-over-year to $135.2 million, compared with a TTM value of $135.2 million through Sep 2025, up 2.12%, and an annual FY2024 reading of $132.1 million, changed N/A over the prior year.
  • Shares Outstanding (Diluted Average) was $135.2 million for Q3 2025 at Community Health Systems, up from $134.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $135.2 million in Q3 2025 and bottomed at $130.1 million in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 4 years is $132.1 million, with a median of $132.1 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) grew 13.67% in 2021, then decreased 0.41% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $130.6 million in 2021, then decreased by 0.41% to $130.1 million in 2022, then rose by 1.57% to $132.1 million in 2024, then grew by 2.34% to $135.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CYH at $135.2 million in Q3 2025, $134.2 million in Q2 2025, and $132.1 million in Q4 2024.